ALVO · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Alvotech

—Past month
Price unavailable
  • 52W range2.94–9.05
  • Market cap2.08B

Latest news

Loading...

About

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company provides AVT02, a high concentration, low-volume adalimumab formulation biosimilar t...

alvotech.com